New findings reveal Black Americans face higher multiple sclerosis, ms rates and mortality while being systematically ...
A Phase 2a trial testing foralumab nasal spray in people with nonactive SPMS has dosed the first patients enrolled at Yale MS ...
2d
Everyday Health on MSNCancer and Multiple Sclerosis: A Mixed StoryA cancer diagnosis has hit very close to home in recent months. It’s likely that cancer has also struck close to most of ...
The National Institutes of Health has been integral to scientific progress in treating countless human diseases. Without its ...
A new study from researchers in France has found that taking high doses of vitamin D every two weeks may help reduce disease ...
Researchers found that higher ocrelizumab exposure over 10 years was associated with less risk of disability progression in ...
Gabryelle “Gabby” Scholfield, a 16-year-old student-athlete at Edmondson Westside High School in Baltimore, who plays center ...
A new report indicates that for every 1,000 U.S. employees, five autoimmune conditions drive an estimated $562,000 in excess ...
4d
Clinical Trials Arena on MSNTiziana Life Sciences begins dosing in trial of therapy for multiple sclerosisThe trial aims to evaluate the antibody’s efficacy in treating non-active secondary progressive multiple sclerosis.
Video Quality Speed 00:00 03:59 El Paso woman creates support network for MS patients lacking local specialists Her efforts ...
Nearly 50% of MS patients report pronounced fatigue, which has a significantly negative impact on their well-being, a Finnish ...
Researchers from CHU Nîmes, Université Montpellier, and multiple MS centers in France have found that oral cholecalciferol in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results